Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biomea Plans To Advance Menin Inhibitor In Two Type 2 Diabetes Subgroups
Oct 07 2025
•
By
Joseph Haas
Biomea hopes to bring a diabetes drug forth that addresses the disease's underlying cause
(Shutterstock)
More from Strategy
More from Business